NO20032371L - Makrolidsolvater - Google Patents

Makrolidsolvater

Info

Publication number
NO20032371L
NO20032371L NO20032371A NO20032371A NO20032371L NO 20032371 L NO20032371 L NO 20032371L NO 20032371 A NO20032371 A NO 20032371A NO 20032371 A NO20032371 A NO 20032371A NO 20032371 L NO20032371 L NO 20032371L
Authority
NO
Norway
Prior art keywords
makrolidsolvater
azithromycin
monohydrate
preparation
water
Prior art date
Application number
NO20032371A
Other languages
English (en)
Other versions
NO20032371D0 (no
NO324951B1 (no
Inventor
Victor Centellas
Jose Diago
Rafael Garcia
Johannes Ludescher
Original Assignee
Biochemie Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0031355A external-priority patent/GB0031355D0/en
Application filed by Biochemie Sa filed Critical Biochemie Sa
Publication of NO20032371D0 publication Critical patent/NO20032371D0/no
Publication of NO20032371L publication Critical patent/NO20032371L/no
Publication of NO324951B1 publication Critical patent/NO324951B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Azitromycin i form av et monohydrat som innbefatter fra 4,0% til 6,5% vann, en fremgangsmåte for dets fremstilling og dets anvendelse i farmasøytiske sammensetninger.
NO20032371A 2000-11-27 2003-05-26 Azitromycin og fremgangsmate for fremstilling derav NO324951B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25311900P 2000-11-27 2000-11-27
GB0031355A GB0031355D0 (en) 2000-12-21 2000-12-21 Organic compounds
PCT/EP2001/013760 WO2002042315A2 (en) 2000-11-27 2001-11-26 Macrolide solvates

Publications (3)

Publication Number Publication Date
NO20032371D0 NO20032371D0 (no) 2003-05-26
NO20032371L true NO20032371L (no) 2003-07-10
NO324951B1 NO324951B1 (no) 2008-01-14

Family

ID=26245472

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032371A NO324951B1 (no) 2000-11-27 2003-05-26 Azitromycin og fremgangsmate for fremstilling derav

Country Status (15)

Country Link
US (1) US6949519B2 (no)
EP (1) EP1339730A2 (no)
JP (1) JP2004519430A (no)
KR (1) KR100815163B1 (no)
AU (1) AU2002221895A1 (no)
BG (1) BG66200B1 (no)
CA (1) CA2429639C (no)
CZ (1) CZ303343B6 (no)
EE (1) EE05200B1 (no)
HR (1) HRP20030430B1 (no)
HU (1) HU229488B1 (no)
NO (1) NO324951B1 (no)
PL (1) PL207076B1 (no)
SK (1) SK287814B6 (no)
WO (1) WO2002042315A2 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
EA007618B1 (ru) 2001-05-22 2006-12-29 Пфайзер Продактс Инк. Кристаллический полуторогидрат азитромицина, содержащая его фармацевтическая композиция и способ лечения на его основе
GB0214277D0 (en) * 2002-06-20 2002-07-31 Biochemie Gmbh Organic compounds
US6855813B2 (en) 2002-07-19 2005-02-15 Alembic Limited Process for the preparation of azithromycin monohydrate
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
GB0224197D0 (en) * 2002-10-17 2002-11-27 Biochemie Gmbh Organic compounds
CA2520192A1 (en) * 2003-03-25 2004-10-14 Teva Pharmaceutical Industries Ltd. Degradation products of azithromycin, and methods for their identification
US20050101547A1 (en) * 2003-11-06 2005-05-12 Sadatrezaei Mohsen Stabilized azithromycin composition
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
JP4471941B2 (ja) * 2005-03-10 2010-06-02 山一電機株式会社 半導体装置用ソケット
US20090318375A1 (en) * 2005-06-08 2009-12-24 Hanmi Pharm Co., Ltd Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same
EA201101319A1 (ru) 2009-03-13 2012-04-30 Да Волтерра Композиции и способы элиминации грамотрицательных бактерий

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
RU2066324C1 (ru) * 1987-07-09 1996-09-10 Пфайзер Инк. Кристаллический дигидрат азитромицина и способ его получения
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
PT102006B (pt) 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
PT102130A (pt) * 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
EP1152765B1 (en) * 1998-11-30 2004-10-13 Teva Pharmaceutical Industries Ltd. Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
US6703372B1 (en) 1999-06-29 2004-03-09 Biochemie S.A. Macrolides
ES2177373B1 (es) 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina

Also Published As

Publication number Publication date
HRP20030430A2 (en) 2005-04-30
EE05200B1 (et) 2009-08-17
EE200300255A (et) 2003-08-15
CA2429639C (en) 2009-07-14
JP2004519430A (ja) 2004-07-02
US20040053862A1 (en) 2004-03-18
PL361276A1 (en) 2004-10-04
CA2429639A1 (en) 2002-05-30
NO20032371D0 (no) 2003-05-26
SK6352003A3 (en) 2003-11-04
EP1339730A2 (en) 2003-09-03
AU2002221895A1 (en) 2002-06-03
BG66200B1 (bg) 2012-01-31
PL207076B1 (pl) 2010-10-29
NO324951B1 (no) 2008-01-14
HUP0302099A3 (en) 2009-08-28
KR100815163B1 (ko) 2008-03-19
KR20030055305A (ko) 2003-07-02
CZ20031439A3 (cs) 2003-10-15
BG107832A (bg) 2004-07-30
WO2002042315A3 (en) 2002-10-31
CZ303343B6 (cs) 2012-08-08
WO2002042315A2 (en) 2002-05-30
HU229488B1 (hu) 2014-01-28
US6949519B2 (en) 2005-09-27
HUP0302099A2 (hu) 2003-10-28
HRP20030430B1 (en) 2011-11-30
SK287814B6 (sk) 2011-11-04

Similar Documents

Publication Publication Date Title
NO20032371L (no) Makrolidsolvater
NL350075I2 (no)
HUP0302230A3 (en) Polyarylcarboxamides useful as lipid lowering agents, process for producing them and pharmaceutical compositions containing them
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
DE60236102D1 (en) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
HUP0400781A3 (en) Process for the crystallization of (r)- or (s)-lansoprazole, the prepared crystalls and pharmaceutical compositions containing them and their use
HUP0402063A3 (en) Indole-2-carboxamides process for producing them, pharmaceutical compositions containing them and use thereof
DE60022230D1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
HRP20090113T3 (en) C-aryl glucoside sglt2 inhibitors and method for their production
ES2189768T3 (es) Sintesis regioselectiva de derivados de rapamicina.
NO20020684L (no) 3(5)-aminopyrazolderivater, fremgangsmåtet for deres fremstilling og deres anvendelse som antitumormidler
TW200510375A (en) New compounds
HUP0301022A3 (en) Thiotropininum bromide monohydrate, method for producing the same and the use thereof for the production of a pharmaceutical composition
HUP0301651A3 (en) Indolylmaleimide derivatives, pharmaceutical compositions containing them, process for producing them and their use
TR200400072T4 (tr) Novel Biarylcarboxamides Biarylcarboxamide Nouveaux Biarylcarboxamides
HUP0102723A3 (en) New diphenylurea derivatives, process for their preparation and pharmaceutical compositions containing them
IL158898A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND DERIVATIVES THEREOF
ATE534656T1 (de) Neue oligosaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
HUP0303006A3 (en) Retinoids for the treatment of emphysema, process for their preparation and pharmaceutical compositions containing them
DK1322158T3 (da) Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
HUP0202233A3 (en) Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them
HUP0500137A2 (en) Pyrrolidine-2-ones as factor xa inhibitors, process for producing them and pharmaceutical compositions containing the same
DK1122254T3 (da) 4-sulfonamidpiperidinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DE60121804D1 (de) Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees